Pathfinder

Platform Development vs. Molecule-Specific Process Development: Which Strategy Is Better for Biologics?

Nice Insight

Biologics Platform

Platform-Based Drug Substance Development: Applying Prior Knowledge Across Modalities

Mathias Kahl

IDT Biologika

Masked Antibody

Expanding the Oncology Therapeutic Window Through Masked Antibody Technology

Sean McCarthy, Ph.D; David Alvaro, Ph.D.

CytomX Therapeutics

Vaccines

The Next Generation of Vaccine Platforms

David Alvaro, Ph.D.

Pharma's Almanac

ADC Platform

From mAbs to ADCs: Rethinking the Platform Manufacturing Model

David Alvaro, Ph.D.

Pharma's Almanac